GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NUTEX Investments PLC (BUD:NUTEX) » Definitions » EV-to-EBITDA

NUTEX Investments (BUD:NUTEX) EV-to-EBITDA : -11.29 (As of Apr. 27, 2024)


View and export this data going back to 1996. Start your Free Trial

What is NUTEX Investments EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, NUTEX Investments's enterprise value is Ft-2,010.54 Mil. NUTEX Investments's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was Ft178.06 Mil. Therefore, NUTEX Investments's EV-to-EBITDA for today is -11.29.

The historical rank and industry rank for NUTEX Investments's EV-to-EBITDA or its related term are showing as below:

BUD:NUTEX' s EV-to-EBITDA Range Over the Past 10 Years
Min: -2490.72   Med: -18.29   Max: 22.77
Current: -11.29

During the past 13 years, the highest EV-to-EBITDA of NUTEX Investments was 22.77. The lowest was -2490.72. And the median was -18.29.

BUD:NUTEX's EV-to-EBITDA is ranked better than
99.86% of 708 companies
in the Drug Manufacturers industry
Industry Median: 14.19 vs BUD:NUTEX: -11.29

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-27), NUTEX Investments's stock price is Ft14.35. NUTEX Investments's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was Ft1.130. Therefore, NUTEX Investments's PE Ratio for today is 12.70.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


NUTEX Investments EV-to-EBITDA Historical Data

The historical data trend for NUTEX Investments's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NUTEX Investments EV-to-EBITDA Chart

NUTEX Investments Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -145.96 -18.69 -105.27 -15.31 -11.42

NUTEX Investments Semi-Annual Data
Dec13 Jun14 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -105.27 - -15.31 - -11.42

Competitive Comparison of NUTEX Investments's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, NUTEX Investments's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NUTEX Investments's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NUTEX Investments's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where NUTEX Investments's EV-to-EBITDA falls into.



NUTEX Investments EV-to-EBITDA Calculation

NUTEX Investments's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=-2010.537/178.064
=-11.29

NUTEX Investments's current Enterprise Value is Ft-2,010.54 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. NUTEX Investments's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was Ft178.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NUTEX Investments  (BUD:NUTEX) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

NUTEX Investments's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=14.35/1.130
=12.70

NUTEX Investments's share price for today is Ft14.35.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. NUTEX Investments's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was Ft1.130.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


NUTEX Investments EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of NUTEX Investments's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


NUTEX Investments (BUD:NUTEX) Business Description

Traded in Other Exchanges
N/A
Address
Telepes u. 53., Budapest, HUN, 1147
NUTEX Investments PLC operates as a drug manufacturer in Hungary. The company is engaged in production of products that focuses on health, vitality, and natural ingredients.

NUTEX Investments (BUD:NUTEX) Headlines

No Headlines